Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TLSA — Tiziana Life Sciences Ltd

CIK 1423053 MIAMI, FL
Back to TLSA Full portfolio

Position in TLSA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$102,684
+$61,625 QoQ
Shares Held
80,222
+128.6% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 30 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLSA Over Time

Shares Held

Position Value (USD)

Derivatives in TLSA

reported options exposure · as of Mar 31, 2025
CallValue
$25,920
CallShares
24,000
PutValue
$864
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. TLSA ranks #351 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in TLSA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $102,684 80,222
2026-03-31 $41,059 35,094
2025-06-30 $314,404 198,990
2025-03-31 $25,920 24,000
2025-03-31 $864 800
2024-09-30 $18,432 19,200
2024-09-30 $100,119 104,291
2023-12-31 $6,664 11,900
2022-06-30 $37,151 49,535
2022-03-31 $14,671 13,973
2021-12-31 $13,056 13,600